BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38306893)

  • 1. Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients.
    Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Orrell C; Schäfer G
    EBioMedicine; 2024 Feb; 100():104986. PubMed ID: 38306893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa.
    Blumenthal MJ; Schutz C; Barr D; Locketz M; Marshall V; Whitby D; Katz AA; Uldrick T; Meintjes G; Schäfer G
    J Infect Dis; 2019 Jul; 220(5):841-851. PubMed ID: 31004430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.
    Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Tincho MB; Burgers WA; Orrell C; Schäfer G
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's Sarcoma-Associated Herpesvirus, but Not Epstein-Barr Virus, Co-infection Associates With Coronavirus Disease 2019 Severity and Outcome in South African Patients.
    Blumenthal MJ; Lambarey H; Chetram A; Riou C; Wilkinson RJ; Schäfer G
    Front Microbiol; 2021; 12():795555. PubMed ID: 35069495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi's Sarcoma Patients in South Africa.
    Tibenderana RM; Blumenthal MJ; Bukajumbe E; Schäfer G; Mohamed Z
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
    Labo N; Miley W; Benson CA; Campbell TB; Whitby D
    AIDS; 2015 Jun; 29(10):1217-25. PubMed ID: 26035321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
    Min J; Katzenstein DA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
    Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
    J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
    Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
    HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
    Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
    Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.
    Stolka K; Ndom P; Hemingway-Foday J; Iriondo-Perez J; Miley W; Labo N; Stella J; Abassora M; Woelk G; Ryder R; Whitby D; Smith JS
    Cancer Epidemiol; 2014 Apr; 38(2):137-43. PubMed ID: 24631417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
    Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
    AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Kaposi's sarcoma associated herpesvirus among men attending sexually transmitted infections clinics in Anhui, China.
    Wang J; Liu S; Cao Y; Yang L; Chen Y; Minhas V; Wood C; Zhang T
    J Med Virol; 2016 Feb; 88(2):304-11. PubMed ID: 26147809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral profiling identifies multiple subtypes of Kaposi's sarcoma.
    Hosseinipour MC; Sweet KM; Xiong J; Namarika D; Mwafongo A; Nyirenda M; Chiwoko L; Kamwendo D; Hoffman I; Lee J; Phiri S; Vahrson W; Damania B; Dittmer DP
    mBio; 2014 Sep; 5(5):e01633-14. PubMed ID: 25249280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children.
    Olp LN; Minhas V; Gondwe C; Kankasa C; Wojcicki J; Mitchell C; West JT; Wood C
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26185193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Kaposi's sarcoma-associated herpesvirus and transfusion-transmissible infections in Tanzanian blood donors.
    Lidenge SJ; Tran T; Tso FY; Ngowi JR; Shea DM; Mwaiselage J; Wood C; West JT
    Int J Infect Dis; 2020 Jun; 95():204-209. PubMed ID: 32294540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Toll-Like Receptor 3 Polymorphisms with Kaposi's Sarcoma-Associated Herpesvirus Infection Among Human Immunodeficiency Virus-Infected Individuals in Xinjiang, China.
    Zhang X; Wu X; Wang H; Xu Y; Li Y; Chen T; Zhang T
    Viral Immunol; 2023 May; 36(4):290-297. PubMed ID: 37040285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.